Dr. Erickson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
440 Medical Dr
Ste 4
Bountiful, UT 84010Fax+1 801-294-8488
Education & Training
Saint Louis University School of MedicineClass of 2002
Certifications & Licensure
UT State Medical License 2005 - 2026
PA State Medical License 2002 - 2005- American Board of Family Medicine Family Medicine
Clinical Trials
- ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry Start of enrollment: 2011 Aug 01
Publications & Presentations
PubMed
- 28 citationsImidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosin...Steve D. Fidanze, Scott A. Erickson, Gary T. Wang, Robert A. Mantei, Richard F. Clark
Bioorganic & Medicinal Chemistry Letters. 2010-04-15 - 122 citationsStructure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and SelectivityMilan Bruncko, Le Wang, George S. Sheppard, Darren C. Phillips, Stephen K. Tahir
Journal of Medicinal Chemistry. 2015-02-26 - 54 citationsTumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.Jieyi Wang, George S. Sheppard, Pingping Lou, Megumi Kawai, Nwe Y. Bamaung
Cancer Research. 2003-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
